{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:25:18Z","timestamp":1760981118454},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1991,4,1]],"date-time":"1991-04-01T00:00:00Z","timestamp":670464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ital J Neuro Sci"],"published-print":{"date-parts":[[1991,4]]},"DOI":"10.1007\/bf02337027","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T17:20:15Z","timestamp":1142356815000},"page":"157-161","source":"Crossref","is-referenced-by-count":7,"title":["Treatment of progressive supranuclear palsy with methysergide. A clinical study"],"prefix":"10.1007","volume":"12","author":[{"given":"G.","family":"Di Trapani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Stampatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"La Cara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Azzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Vaccario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02337027_CR1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/brain\/92.3.663","volume":"92","author":"S. Behrman","year":"1969","unstructured":"Behrman S., Carroll J.D., Janota I., Matthews W.B.:Progressive supranuclear palsy: a clinico-pathological study of four cases. Brain 92: 663\u2013678, 1969.","journal-title":"Brain"},{"key":"BF02337027_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02336701","volume":"1","author":"A. Brusa","year":"1980","unstructured":"Brusa A., Mancardi G.L., Bugiani O.:Progressive supranuclear palsy 1979: an overview. Ital. J. Neurol. Sci. 1: 205\u2013222, 1980.","journal-title":"Ital. J. Neurol. Sci."},{"key":"BF02337027_CR3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/WNL.35.6.936","volume":"35","author":"A.S. Ducombe","year":"1985","unstructured":"Ducombe A.S., Lees A.J.:Methysergide in progressive supranuclear palsy. Neurology 35: 936, 1985.","journal-title":"Neurology"},{"key":"BF02337027_CR4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1212\/WNL.31.4_Part_2.442","volume":"31","author":"S. Haldeman","year":"1981","unstructured":"Haldeman S., Goldman J.W., Hyde J., Pribram H.F.W.:Progressive supranuclear palsy, computed tomography and response to antiparkinsonian drugs. Neurology 31: 442\u2013445, 1981.","journal-title":"Neurology"},{"key":"BF02337027_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ana.410130308","volume":"13","author":"J.A. Jackson","year":"1983","unstructured":"Jackson J.A., Jankovich J., Ford J.:Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Ann. Neurol. 13: 273\u2013278, 1983.","journal-title":"Ann. Neurol."},{"key":"BF02337027_CR6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/WNL.33.4.505","volume":"33","author":"J. Jankovich","year":"1983","unstructured":"Jankovich J.:Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy. Neurology 33: 505\u2013507, 1983.","journal-title":"Neurology"},{"key":"BF02337027_CR7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.1982.00510180065029","volume":"39","author":"J.N. Kvale","year":"1982","unstructured":"Kvale J.N.:Amitriptyline in the management of progressive supranuclear palsy. Arch. Neurol. 39: 387\u2013388, 1982.","journal-title":"Arch. Neurol."},{"key":"BF02337027_CR8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archneur.1978.00500320023005","volume":"35","author":"A.J. Lees","year":"1978","unstructured":"Lees A.J., Haddad S., Show K.M., Kohout L.J., Stern G.M.:Bromocriptine in Parkinsonism. Arch. Neurol. 35: 503\u2013505, 1978","journal-title":"Arch. Neurol."},{"key":"BF02337027_CR9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/jnnp.45.3.261","volume":"45","author":"A. Neophytides","year":"1982","unstructured":"Neophytides A., Lieberman A.N., Goldstein M., et al.:The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy. J. Neurol. Neuosurg. Psychiatry 45: 261\u2013263, 1982","journal-title":"J. Neurol. Neuosurg. Psychiatry"},{"key":"BF02337027_CR10","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1212\/WNL.35.8.1189","volume":"35","author":"G.C. Newman","year":"1985","unstructured":"Newman G.C.:Treatment of progressive supranuclear palsy with tricyclic antidepressant. Neurology 35: 1189\u20131193, 1985","journal-title":"Neurology"},{"key":"BF02337027_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000115198","volume":"20","author":"G.W. Paulson","year":"1981","unstructured":"Paulson G.W., Lowery H.W., Taylor G.C.:Progressive supranuclear palsy: pneumoencephalography, electronystagmography and treatment with methysergide. Eur. Neurol. 20: 13\u201316, 1981.","journal-title":"Eur. Neurol."},{"key":"BF02337027_CR12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0013-4694(80)90226-6","volume":"49","author":"J.L. Perret","year":"1980","unstructured":"Perret J.L., Jouvet M.:Etude du sommeil dans la paralysie supra-nucleaire progressive. Electroencephalogr. Clin. Neurophysiol. 49: 323\u2013329, 1980.","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"BF02337027_CR13","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.31.12.1507","volume":"31","author":"R.D. Rafal","year":"1981","unstructured":"Rafal R.D., Grimm R.J.:Progressive supranuclear palsy: functional analysis of the response to methysergide and antiparkinsonian agents. Neurology 31: 1507\u20131518, 1981.","journal-title":"Neurology"},{"key":"BF02337027_CR14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","volume":"10","author":"J.C. Steele","year":"1964","unstructured":"Steele J.C., Richardson J.C., Olszewski J.:Progressive supranuclear palsy. Arch. Neurol. 10: 333\u2013359, 1964.","journal-title":"Arch. Neurol."}],"container-title":["The Italian Journal of Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02337027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02337027\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02337027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T17:11:23Z","timestamp":1557940283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02337027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1991,4]]}},"alternative-id":["BF02337027"],"URL":"https:\/\/doi.org\/10.1007\/bf02337027","relation":{},"ISSN":["0392-0461","1126-5442"],"issn-type":[{"value":"0392-0461","type":"print"},{"value":"1126-5442","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,4]]}}}